Litcius/Paper detail

Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients

Yasuhiro Nakamura, Y. Nakamura, Kenjiro Namikawa, Kenji Yoshino, Shusuke Yoshikawa, Hiroshi Uchi, K. Goto, Y. Nakamura, Y. Nakamura, Satoshi Fukushima, Yukiko Kiniwa, Tatsuya Takenouchi, Hisashi Uhara, Tsuyoshi Kawai, Naohito Hatta, Takeru Funakoshi, Yukiko Teramoto, Atsushi Otsuka, Haruki Doi, Dai Ogata, Shigeto Matsushita, Taiki Isei, Toshihiko Hayashi, Yuki Shibayama, N. Yamazaki

2020Annals of Oncology140 citationsDOI

Topics & Concepts

MedicineMulticenter studyOncologyMelanomaInternal medicineDermatologyCancer researchRandomized controlled trialCutaneous Melanoma Detection and ManagementNonmelanoma Skin Cancer StudiesCancer Immunotherapy and Biomarkers
Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients | Litcius